These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28886887)

  • 21. Medical use of cannabis in Australia: "medical necessity" defences under current Australian law and avenues for reform.
    Martin C
    J Law Med; 2014 Jun; 21(4):875-99. PubMed ID: 25087368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
    Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details.
    Pacula RL; Powell D; Heaton P; Sevigny EL
    J Policy Anal Manage; 2015; 34(1):7-31. PubMed ID: 25558490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A regulatory take on cannabis and cannabinoids for medicinal use in the European Union.
    Lipnik-Štangelj M; Razinger B
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):12-18. PubMed ID: 32597142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies.
    Sznitman SR; Bretteville-Jensen AL
    Harm Reduct J; 2015 Oct; 12():46. PubMed ID: 26467203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis.
    Hallinan CM; Gunn JM; Bonomo YA
    BMJ Open; 2021 Oct; 11(10):e054044. PubMed ID: 34686558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in reducing cannabis-related harm in Australia.
    Hall WD
    Drug Alcohol Rev; 2009 Mar; 28(2):110-6. PubMed ID: 19320694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students.
    Vujcic I; Pavlovic A; Dubljanin E; Maksimovic J; Nikolic A; Sipetic-Grujicic S
    Subst Use Misuse; 2017 Jul; 52(9):1225-1231. PubMed ID: 28605305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians].
    Cremer-Schaeffer P; Knöss W; Broich K
    Schmerz; 2019 Oct; 33(5):378-383. PubMed ID: 31243538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of medical cannabis laws on juvenile cannabis use.
    Stolzenberg L; D'Alessio SJ; Dariano D
    Int J Drug Policy; 2016 Jan; 27():82-8. PubMed ID: 26123892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018.
    Cox C
    Health Policy; 2018 Mar; 122(3):205-209. PubMed ID: 29429644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.
    Hall W; Stjepanović D; Caulkins J; Lynskey M; Leung J; Campbell G; Degenhardt L
    Lancet; 2019 Oct; 394(10208):1580-1590. PubMed ID: 31657733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding and learning from the diversification of cannabis supply laws.
    Kilmer B; Pacula RL
    Addiction; 2017 Jul; 112(7):1128-1135. PubMed ID: 27891693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug policy reform and the reclassification of cannabis in England and Wales: A cautionary tale.
    Shiner M
    Int J Drug Policy; 2015 Jul; 26(7):696-704. PubMed ID: 25959525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recreational cannabis use: pleasures and pitfalls.
    Rella JG
    Cleve Clin J Med; 2015 Nov; 82(11):765-72. PubMed ID: 26540327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the public health impacts of legalizing recreational cannabis use in the USA.
    Hall W; Weier M
    Clin Pharmacol Ther; 2015 Jun; 97(6):607-15. PubMed ID: 25777798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A "not-for-profit" regulatory model for legal recreational cannabis: Insights from the regulation of gaming machine gambling in New Zealand.
    Wilkins C
    Int J Drug Policy; 2018 Mar; 53():115-122. PubMed ID: 29346087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum to: Cancer patients' use of and attitudes towards medicinal cannabis.
    Drosdowsky A; Blaschke S; Koproski T; Fullerton S; Thakerar A; Ellen S; Phipps-Nelson J; de Neef C
    Aust Health Rev; 2020 Aug; 44(4):656. PubMed ID: 32755535
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer patients' use of and attitudes towards medicinal cannabis.
    Drosdowsky A; Blaschke S; Koproski T; Fullerton S; Thakerar A; Ellen S; Phipps-Nelson J; de Neef C
    Aust Health Rev; 2020 Aug; 44(4):650-655. PubMed ID: 31959279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.